-
1
-
-
84870165132
-
Cardiovascular diseases (cvds)
-
World Health Organisation. (accessed 1 Nov 2012
-
World Health Organisation. Cardiovascular diseases (CVDs). Fact Sheet No 317. 2012. http://www.who.int./mediacentre/factsheets/fs317/en/index.html (accessed 1 Nov 2012).
-
(2012)
Fact Sheet
, Issue.317
-
-
-
2
-
-
82355175158
-
Aha/accf secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: A guideline from the american heart association and american college of cardiology foundation
-
Smith SC, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011;124:2458-73.
-
(2011)
Circulation
, vol.124
, pp. 2458-73
-
-
Smith, S.C.1
Benjamin, E.J.2
Bonow, R.O.3
-
3
-
-
79451474588
-
Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: A guideline for healthcare professionals from the american heart association/american stroke association
-
Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:227-76.
-
(2011)
Stroke
, vol.42
, pp. 227-76
-
-
Furie, K.L.1
Kasner, S.E.2
Adams, R.J.3
-
5
-
-
84871296077
-
Use of a multidrug pill in reducing cardiovascular events (umpire): Rationale and design of a randomised controlled trial of a cardiovascular preventive polypill-based strategy in india and europe
-
Thom S, Field J, Poulter N, et al. Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE): rationale and design of a randomised controlled trial of a cardiovascular preventive polypill-based strategy in India and Europe. Eur J Prev Cardiol 2012.
-
(2012)
Eur J Prev Cardiol
-
-
Thom, S.1
Field, J.2
Poulter, N.3
-
6
-
-
84878458934
-
-
(accessed 1 Nov 2012
-
http://cpr.sagepub.com/search/results?fulltext=umpire&x=0&y= 0&submit=yes&journal-set=spcpr&src=selected&andorexactfulltext= and (accessed 1 Nov 2012).
-
-
-
-
7
-
-
0026911107
-
Prospective randomized open blinded end-point (probe) study. A novel design for intervention trials. Prospective randomized open blinded end-point
-
Hansson L, Hedner T, Dahlof B. Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective randomized open blinded end-point. Blood Press 1992;1:113-19.
-
(1992)
Blood Press
, vol.1
, pp. 113-19
-
-
Hansson, L.1
Hedner, T.2
Dahlof, B.3
-
8
-
-
0026554613
-
Patient non-compliance: Deviance or reasoned decision-making?
-
Donovan JL, Blake DR. Patient non-compliance: deviance or reasoned decision-making? Soc Sci Med 1992;34:507-13.
-
(1992)
Soc Sci Med
, vol.34
, pp. 507-13
-
-
Donovan, J.L.1
Blake, D.R.2
-
9
-
-
3142745354
-
The health effects of restricting prescription medication use because of cost
-
Heisler M, Langa KM, Eby EL, et al. The health effects of restricting prescription medication use because of cost. Med Care 2004;42:626-34.
-
(2004)
Med Care
, vol.42
, pp. 626-34
-
-
Heisler, M.1
Langa, K.M.2
Eby, E.L.3
-
10
-
-
33644871787
-
Process evaluation in randomised controlled trials of complex interventions
-
DOI 10.1136/bmj.332.7538.413
-
Oakley A, Strange V, Bonell C, et al. Process evaluation in randomised controlled trials of complex interventions. BMJ 2006;332:413-16. (Pubitemid 43797387)
-
(2006)
British Medical Journal
, vol.332
, Issue.7538
, pp. 413-416
-
-
Oakley, A.1
Strange, V.2
Bonell, C.3
Allen, E.4
Stephenson, J.5
-
14
-
-
0036207215
-
Ethics of qualitative research: Are there special issues for health services research?
-
Richards HM, Schwartz LJ. Ethics of qualitative research: are there special issues for health services research? Fam Pract 2002;19:135-9. (Pubitemid 34257773)
-
(2002)
Family Practice
, vol.19
, Issue.2
, pp. 135-139
-
-
Richards, H.M.1
Schwartz, L.J.2
-
15
-
-
81255143870
-
What determines adherence to treatment in cardiovascular disease prevention? Protocol for a mixed methods preference study
-
(accessed 1 Nov 2012
-
Jan S, Usherwood T, Brien JA, et al. What determines adherence to treatment in cardiovascular disease prevention? Protocol for a mixed methods preference study. BMJ Open 2011;1. http://bmjopen.bmj. com/content/1/2/e000372. full.pdf (accessed 1 Nov 2012).
-
(2011)
BMJ Open
, pp. 1
-
-
Jan, S.1
Usherwood, T.2
Brien, J.A.3
-
16
-
-
0142017677
-
-
World Health Organisation. accessed 1 Nov 2012
-
World Health Organisation. Adherence for long-term therapies: evidence for action. 2003. http://whqlibdoc.who.int/publications/2003/9241545992.pdf (accessed 1 Nov 2012).
-
(2003)
Adherence for long-term therapies: evidence for action.
-
-
-
17
-
-
34249010801
-
Health beliefs, disease severity, and patient adherence: A meta-Analysis
-
DiMatteo MR, Haskard KB, Williams SL. Health beliefs, disease severity, and patient adherence: a meta-Analysis. Med Care 2007;45:521-8.
-
(2007)
Med Care
, vol.45
, pp. 521-8
-
-
DiMatteo, M.R.1
Haskard, K.B.2
Williams, S.L.3
|